These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2368131)

  • 41. Prevention of chronic rejection with immunoregulatory cells induced by intrathymic immune modulation with class I allopeptides.
    Shirwan H; Mhoyan A; Kakoulidis TP; Yolcu ES; Ibrahim S
    Am J Transplant; 2003 May; 3(5):581-9. PubMed ID: 12752314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cellular basis of cardiac allograft rejection: VIII. Mechanisms underlying delayed allograft rejection in PVG C6-deficient rats.
    Merten S; Chen JC; Ha H; Plain K; Boyd RA; Penny MJ; Leenaerts P; Hall BM
    Transplantation; 1998 May; 65(9):1152-8. PubMed ID: 9603160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of transplantation tolerance in rats by spleen allografts. I. Evidence that rats tolerant of spleen allografts contain two phenotypically distinct T suppressor cells.
    Duncan WR; Stepkowski SM; Bitter-Suermann H
    Transplantation; 1986 May; 41(5):626-33. PubMed ID: 2939608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of transplantation tolerance in rats by spleen allografts. II. Evidence that W3/25+ T suppressor/inducer and OX8+ T suppressor/effector cells are required to mediate specific unresponsiveness.
    Stepkowski SM; Bitter-Suermann H; Duncan WR
    Transplantation; 1987 Sep; 44(3):443-8. PubMed ID: 2957840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance.
    Knechtle SJ; Wolfe JA; Burchette J; Sanfilippo F; Bollinger RR
    Transplantation; 1987 Feb; 43(2):169-72. PubMed ID: 3544371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A rat model of pregnancy-induced sensitization to transplants.
    Qian Z; Liu J; Fox-Talbot K; Wasowska BA; Baldwin WM
    Transplant Proc; 2005; 37(1):96-7. PubMed ID: 15808559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A three-cell cluster hypothesis for noncognate T-B collaboration via direct T cell recognition of allogeneic dendritic cells.
    Kelly CM; Benham AM; Sawyer GJ; Dalchau R; Fabre JW
    Transplantation; 1996 Apr; 61(7):1094-9. PubMed ID: 8623191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selection of lowly immunogenic and highly tolerogenic donor and recipient allochimeric class I major histocompatibility complex proteins.
    Perez J; Stepkowski SM; Song P; Trawick B; Wang ME; Janczewska S; Kahan BD
    Transplantation; 2003 Oct; 76(8):1201-7. PubMed ID: 14578754
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression of kidney allograft rejection across full MHC barriers by recipient-specific antibodies to class II MHC antigens.
    Priestley CA; Spencer SC; Sawyer GJ; Fabre JW
    Transplantation; 1992 May; 53(5):1024-32. PubMed ID: 1585464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative contribution of major histocompatibility complex antigens to the immunogenicity of corneal allografts.
    Treseler PA; Sanfilippo F
    Transplantation; 1986 Apr; 41(4):508-14. PubMed ID: 3515652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.
    Chueh SC; Tian L; Wang M; Wang ME; Stepkowski SM; Kahan BD
    Transplantation; 1997 Nov; 64(10):1407-14. PubMed ID: 9392303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
    Goss JA; Nakafusa Y; Yu S; Flye MW
    Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Allograft rejection in athymic nude rats by transferred T-cell subsets. I. The response of naive CD4+ and CD8+ thoracic duct lymphocytes to complete allogeneic incompatibilities.
    Whitby EH; Sparshott SM; Bell EB
    Immunology; 1990 Jan; 69(1):78-84. PubMed ID: 2138126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats.
    Wang ME; Stepkowski SM; Ferraresso M; Kahan BD
    Transplantation; 1992 Oct; 54(4):704-9. PubMed ID: 1412762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1999 Nov; 68(9):1402-9. PubMed ID: 10573082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.